Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia (opens ClinicalTrials.gov)
- Sponsor
- Janssen Cilag S.A.S.
- Enrolment
- 180
- Started
- 2024-05-27
- Last update
- 2026-11-03
Conditions: Leukemia, Lymphocytic, Chronic, B-Cell
Interventions: Individual Physical Activity Intervention (IPAI), Ibrutinib